NYSEMKT: ARMPArmata Pharmaceuticals Inc Stock Ownership - Who owns Armata Pharmaceuticals?
Insider buying vs selling
Have Armata Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Deborah Birx | Chief Executive Officer | 2026-03-14 | 4,919 | $10.54 | $51.85kSell |
| Pierre Kyme | Chief Business Officer | 2026-03-14 | 1,030 | $10.54 | $10.86kSell |
| Deborah Birx | Chief Executive Officer | 2025-07-10 | 13,637 | $2.27 | $30.96kSell |
ARMP insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ARMP insiders and whales buy or sell their stock.
ARMP Shareholders
What type of owners hold Armata Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Innoviva Inc | 68.31% | 25,076,769 | $190.08M | Insider |
| Randal J. Kirk | 60.39% | 22,169,127 | $168.04M | Insider |
| Biogen Inc | 37.97% | 13,939,158 | $105.66M | Insider |
| Elan Corp PLC | 31.67% | 11,626,282 | $88.13M | Insider |
| Austin W. Greenhouse David M. Marxe | 6.42% | 2,355,475 | $17.85M | Insider |
| Madison Asset Management LLC | 5.74% | 2,107,675 | $15.98M | Institution |
| Delta Dental Of Wisconsin Inc | 5.74% | 2,107,675 | $15.98M | Insider |
| Louis P. Lacasse | 3.95% | 1,450,185 | $10.99M | Insider |
| Delta Dental Plan Of Michigan Inc | 3.45% | 1,265,802 | $9.59M | Insider |
| Jeremy Curnock Cook | 1.12% | 411,435 | $3.12M | Insider |
ARMP vs Biotech Stocks
Armata Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.